歯科麻酔薬市場 – 2030年までの世界予測

本市場調査は、様々なセグメントにわたる歯科麻酔薬市場に焦点を当てています。その目的は、薬剤の種類、投与経路、エンドユーザー、地理的地域など、様々なカテゴリーにおける市場規模と成長の可能性を推定することです。さらに、本調査には、市場の主要プレーヤーの包括的な競合分析と企業プロフィールが含まれています。本分析では、各社の製品ラインナップ、最近の動向、そして市場における主要戦略に関する重要な考察も取り上げています。

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period.

世界の歯科麻酔薬市場は、予測期間中に年平均成長率4.0%で成長し、2025年の14億8,000万米ドルから2030年には18億米ドルに達すると予測されています。

The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent.

歯科麻酔薬の世界市場は、歯科疾患の発生率上昇に伴い歯科治療件数が増加していることから拡大しています。さらに、口腔衛生と審美歯科の重要性に対する意識が高まり、歯科治療を受ける人が増えています。多くの地域では、所得水準の向上と医療インフラの整備により、歯科医療へのアクセスが容易になっています。さらに、高齢化人口の増加も、これらのサービスに対する需要を押し上げると予想されています。しかしながら、予測期間中は、歯科医師不足や歯科治療に対する保険適用範囲の狭さといった課題が、市場の成長をある程度阻害する可能性があります。

“Articaine is expected to grow at the highest CAGR during the forecast period.”

Articaine is projected to experience the highest CAGR during the forecast period due to its numerous advantages over other types of anesthetics. Unlike other amide anesthetics that contain a benzene ring, articaine features a thiophene ring, which leads to increased lipid solubility and improved penetration into tissues and nerve membranes. This enhanced diffusion through both hard and soft tissues makes articaine particularly effective for mandibular infiltrations, where nerve blocks are often required with other anesthetics. Consequently, dentists find that articaine performs better in areas with dense bone structures. Additionally, various studies have confirmed its safety profile when used appropriately, even among elderly and pediatric patient populations. These advantages contribute to the growing popularity of articaine and support its market expansion.

“The topical anesthetics segment is expected to grow at the highest CAGR in the dental anesthetics market, by route of administration.”

The topical anesthetics market is projected to experience the highest growth in the dental anesthetics market, driven by their widespread use in standard procedures, ease of application, non-invasiveness, and ability to provide quick surface anesthesia. Dentists increasingly utilize new technologies such as gels, metered-dose sprays, and patches. Additionally, the introduction of needle-free anesthesia and the availability of topical anesthetics in various flavors contribute to their increased adoption. Although topical anesthetics are limited by their short duration of action, their reliability and broad range of applications continue to fuel market growth.

“Based on end users, the dental clinics segment is expected to dominate the dental anesthetics market during the forecast period.”

The demand for dental anesthetics is primarily driven by the growth of dental clinics in developing regions of Latin America and the Asia Pacific. As dental services become more accessible in countries such as Vietnam, Indonesia, and India, a greater number of patients are seeking surgeries that require effective pain management. Key factors contributing to the expansion of dental clinics include rising incomes among the middle class, urbanization, and an increasing awareness of oral health. Consequently, there is a growing need for reliable topical and local anesthetics, as more dental clinics now offer restorative and cosmetic procedures.

“The Asia Pacific is expected to register the highest CAGR in the dental anesthetics market during the forecast period.”

The dental anesthetics market in the Asia Pacific region is expected to grow at the highest CAGR due to several factors that reflect the changing landscape of healthcare. The rising prevalence of dental infections and greater awareness of oral health drive the demand for dental procedures. Additionally, the region’s large and aging population significantly contributes to increased healthcare spending, which boosts the need for easily accessible and patient-friendly treatment options. Improvements in healthcare infrastructure, higher disposable incomes, and advancements in dental anesthetics will also likely fuel growth in the Asia Pacific dental anesthetics market.

A summary of the main supply-side participants in the dental anesthetics market is provided below for this report:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
• By Region: North America (25%), Europe (23%), Asia Pacific (28%), Latin America (17%), Middle East & Africa (7%)

The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Indústria e Comércio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US).

Research Coverage

The market study focuses on the dental anesthetics market across various segments. Its purpose is to estimate the market size and growth potential across different categories, including drug type, route of administration, end user, and geographic region. Additionally, the study includes a comprehensive competitive analysis of the key players in the market, along with their company profiles. This analysis features important observations regarding their product offerings, recent developments, and key strategies in the market.

Reasons to Buy the Report

The report provides valuable information for market leaders and new entrants in the dental anesthetics market, offering approximate revenue figures for both the overall market and its subsegments. It enables stakeholders to understand the competitive landscape, which can help them better position their businesses and develop effective go-to-market strategies. Additionally, the report offers insights into the current state of the market, including critical drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia).

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   23

1.3           STUDY SCOPE   24

1.3.1        MARKETS COVERED & REGIONAL SCOPE             24

1.3.2        INCLUSIONS & EXCLUSIONS       25

1.3.3        YEARS CONSIDERED      25

1.4           CURRENCY CONSIDERED            26

1.5           UNIT CONSIDERED        26

1.6           STAKEHOLDERS               26

2               RESEARCH METHODOLOGY       27

2.1           RESEARCH DATA              27

2.1.1        SECONDARY DATA          28

2.1.1.1    Key data from secondary sources       29

2.1.2        PRIMARY DATA 30

2.1.2.1    Key data from primary sources           31

2.1.2.2    Key industry insights           32

2.2           MARKET SIZE ESTIMATION         34

2.3           MARKET BREAKDOWN & DATA TRIANGULATION                 39

2.4           MARKET SHARE ESTIMATION    41

2.5           STUDY ASSUMPTIONS  41

2.6           RESEARCH LIMITATIONS             41

2.6.1        SCOPE-RELATED LIMITATIONS                 41

2.6.2        METHODOLOGY-RELATED LIMITATIONS           41

2.7           RISK ASSESSMENT           42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       46

4.1           DENTAL ANESTHETICS MARKET OVERVIEW      46

4.2           ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024)      47

4.3           DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         48

4.4           DENTAL ANESTHETICS MARKET: REGIONAL MIX                 48

4.5           DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS                49

5               MARKET OVERVIEW       50

5.1           INTRODUCTION              50

5.2           MARKET DYNAMICS       51

5.2.1        DRIVERS               51

5.2.1.1    Increasing patient pool for dental treatments  51

5.2.1.1.1 Dental caries and other dental disorders          51

5.2.1.1.2 Geriatric population and edentulism 52

5.2.1.1.3 Periodontal diseases             53

5.2.1.1.4 Changing lifestyles and unhealthy food habits 54

5.2.1.2    Increasing demand for advanced cosmetic dental procedures                 54

5.2.1.3    Technological advancements in anesthetic delivery        55

5.2.2        RESTRAINTS      55

5.2.2.1    Potential adverse effects      55

5.2.3        OPPORTUNITIES              56

5.2.3.1    Rising number of DSOs and growing private equity investments                 56

5.2.3.2    Emerging markets                 58

5.2.3.3    Growing dental tourism      58

5.2.4        CHALLENGES    59

5.2.4.1    Dearth of trained dental practitioners               59

5.2.4.2    Needle phobia       59

5.3           PORTER’S FIVE FORCES ANALYSIS           60

5.3.1        INTENSITY OF COMPETITIVE RIVALRY 61

5.3.2        BARGAINING POWER OF SUPPLIERS       61

5.3.3        BARGAINING POWER OF BUYERS             61

5.3.4        THREAT OF SUBSTITUTES          61

5.3.5        THREAT OF NEW ENTRANTS      62

5.4           REGULATORY ANALYSIS               62

5.4.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             62

5.4.2        REGULATORY LANDSCAPE         65

5.5           INDUSTRY TRENDS         66

5.5.1        METERED SPRAY SYSTEMS          66

5.5.2        JET INJECTION SYSTEMS              66

5.6           REIMBURSEMENT SCENARIO     66

5.7           TECHNOLOGY ANALYSIS             67

5.7.1        KEY TECHNOLOGIES     67

5.7.1.1    Vasoconstrictors   67

5.7.1.2    Buffering agents   67

5.7.2        COMPLEMENTARY TECHNOLOGIES       68

5.7.2.1    Computer-controlled local anesthetic delivery (CCLAD) systems                 68

5.7.3        ADJACENT TECHNOLOGIES       68

5.7.3.1    Reversal agents     68

5.8           KEY CONFERENCES & EVENTS, 2025–2026              69

5.9           PRICING ANALYSIS          70

5.9.1        AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION          70

5.9.2        INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER 70

5.10         TRADE ANALYSIS             71

5.10.1      IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024             72

5.10.2      EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024             72

5.11         PATENT ANALYSIS          73

5.11.1      PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS   73

5.11.2      JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET    73

5.12         VALUE CHAIN ANALYSIS               76

5.13         ECOSYSTEM ANALYSIS  77

5.14         SUPPLY CHAIN ANALYSIS             78

5.15         CASE STUDY ANALYSIS 80

5.15.1      CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY             80

5.15.2      CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA             80

5.15.3      CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES       81

5.16         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       81

5.17         KEY STAKEHOLDERS & BUYING CRITERIA            82

5.17.1      KEY STAKEHOLDERS IN BUYING PROCESS           82

5.17.2      BUYING CRITERIA           83

5.18         ADJACENT MARKET ANALYSIS  84

5.19         UNMET NEEDS/END-USER EXPECTATIONS         84

5.20         IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET 86

5.21         IMPACT OF 2025 US TARIFF – OVERVIEW              86

5.21.1      INTRODUCTION              86

5.21.2      KEY TARIFF RATES          87

5.21.3      PRICE IMPACT ANALYSIS             88

5.21.4      IMPACT ON END-USER INDUSTRIES       88

6               DENTAL ANESTHETICS MARKET, BY DRUG TYPE                 89

6.1           INTRODUCTION              90

6.2           LIDOCAINE        92

6.2.1        RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET 92

6.3           MEPIVACAINE   94

6.3.1        UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET   94

6.4           ARTICAINE         96

6.4.1        IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET        96

6.5           BUPIVACAINE   98

6.5.1        PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH               98

6.6           PRILOCAINE      100

6.6.1        LOWER TOXICITY PROFILE TO FUEL UPTAKE    100

6.7           OTHER DRUG TYPES      101

7               DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION          103

7.1           INTRODUCTION              104

7.2           TOPICAL ANESTHETICS                106

7.2.1        GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND     106

7.3           INJECTABLE ANESTHETICS         108

7.3.1        HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET               108

7.4           SYRINGES            110

7.4.1        ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET               110

7.5           NEEDLES             112

7.5.1        RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH       112

8               DENTAL ANESTHETICS MARKET, BY END USER 114

8.1           INTRODUCTION              115

8.2           HOSPITALS         115

8.2.1        ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET               115

8.3           DENTAL CLINICS             117

8.3.1        RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET      117

8.4           OTHER END USERS         119

9               DENTAL ANESTHETICS MARKET, BY REGION    121

9.1           INTRODUCTION              122

9.2           EUROPE               124

9.2.1        MACROECONOMIC OUTLOOK FOR EUROPE      124

9.2.2        GERMANY           127

9.2.2.1    Favorable government policies for reimbursement to expedite growth    127

9.2.3        ITALY    130

9.2.3.1    Rising adoption of digital dentistry techniques to augment growth    130

9.2.4        SPAIN    132

9.2.4.1    Presence of well-established dental healthcare infrastructure to foster growth         132

9.2.5        FRANCE                134

9.2.5.1    Favorable distribution network and reimbursement scenario to aid growth              134

9.2.6        UK          136

9.2.6.1    Booming geriatric population to stimulate growth          136

9.2.7        REST OF EUROPE             138

9.3           NORTH AMERICA             139

9.3.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 140

9.3.2        US           143

9.3.2.1    High per capita income and quality of treatment to support growth    143

9.3.3        CANADA               144

9.3.3.1    Rising healthcare expenditure to sustain growth             144

9.4           ASIA PACIFIC     146

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 147

9.4.2        SOUTH KOREA  150

9.4.2.1    Growing elderly population to fuel market       150

9.4.3        JAPAN   153

9.4.3.1    Surge in age-related dental issues to promote growth    153

9.4.4        CHINA  155

9.4.4.1    Shift in demographic trend to accelerate growth             155

9.4.5        INDIA    157

9.4.5.1    Growing cosmetic dentistry sector to fuel market           157

9.4.6        AUSTRALIA         159

9.4.6.1    Increasing access to dental services to favor growth       159

9.4.7        REST OF ASIA PACIFIC   160

9.5           LATIN AMERICA                162

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 162

9.5.2        BRAZIL 164

9.5.2.1    Booming dental tourism to contribute to growth            164

9.5.3        ARGENTINA       166

9.5.3.1    Growing focus on oral health to propel market                166

9.5.4        MEXICO                168

9.5.4.1    Affordable dental care costs to amplify growth                168

9.5.5        REST OF LATIN AMERICA             170

9.6           MIDDLE EAST & AFRICA                171

9.6.1        GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET               171

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 171

9.7           GCC COUNTRIES              173

9.7.1        INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET      173

9.7.2        MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 173

10            COMPETITIVE LANDSCAPE         176

10.1         INTRODUCTION              176

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            176

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET              177

10.3         MARKET SHARE ANALYSIS           178

10.4         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 180

10.4.1      STARS   180

10.4.2      EMERGING LEADERS     180

10.4.3      PERVASIVE PLAYERS      181

10.4.4      PARTICIPANTS 181

10.4.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         182

10.4.5.1  Company footprint               182

10.4.5.2  Region footprint   183

10.4.5.3  Drug type footprint              184

10.4.5.4  Route of administration footprint      185

10.5         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        186

10.5.1      PROGRESSIVE COMPANIES         186

10.5.2      RESPONSIVE COMPANIES            186

10.5.3      DYNAMIC COMPANIES  186

10.5.4      STARTING BLOCKS         186

10.5.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 188

10.5.5.1  Detailed list of key startups/SMEs    188

10.5.5.2  Competitive benchmarking of key startups/SMEs          188

10.6         COMPANY VALUATION & FINANCIAL METRICS 189

10.6.1      FINANCIAL METRICS      189

10.6.2      COMPANY VALUATION 189

10.7         BRAND/PRODUCT COMPARISON             190

10.8         COMPETITIVE SCENARIO             191

10.8.1      PRODUCT LAUNCHES   191

10.8.2      DEALS  191

10.8.3      EXPANSIONS     192

10.8.4      OTHER DEVELOPMENTS              192

11            COMPANY PROFILES      193

11.1         KEY PLAYERS     193

11.1.1      SEPTODONT HOLDING                 193

11.1.1.1  Business overview 193

11.1.1.2  Products/Services/Solutions offered 194

11.1.1.3  Recent developments           195

11.1.1.3.1                Product launches  195

11.1.1.3.2                Deals      195

11.1.1.3.3                Expansions             196

11.1.1.4  MnM view              196

11.1.1.4.1                Right to win           196

11.1.1.4.2                Strategic choices   197

11.1.1.4.3                Weaknesses & competitive threats     197

11.1.2      DENTSPLY SIRONA         198

11.1.2.1  Business overview 198

11.1.2.2  Products/Services/Solutions offered 199

11.1.2.3  Recent developments           200

11.1.2.3.1                Deals      200

11.1.2.4  MnM view              201

11.1.2.4.1                Right to win           201

11.1.2.4.2                Strategic choices   201

11.1.2.4.3                Weaknesses & competitive threats     201

11.1.3      PIERREL               202

11.1.3.1  Business overview 202

11.1.3.2  Products/Services/Solutions offered 202

11.1.3.3  Recent developments           203

11.1.3.3.1                Product launches  203

11.1.3.3.2                Deals      203

11.1.3.4  MnM view              204

11.1.3.4.1                Right to win           204

11.1.3.4.2                Strategic choices   204

11.1.3.4.3                Weaknesses & competitive threats     204

11.1.4      HUONS GLOBAL               205

11.1.4.1  Business overview 205

11.1.4.2  Products/Services/Solutions offered 206

11.1.4.3  Recent developments           207

11.1.4.3.1                Expansions             207

11.1.4.3.2                Other developments             207

11.1.4.4  MnM view              207

11.1.4.4.1                Right to win           207

11.1.4.4.2                Strategic choices   207

11.1.4.4.3                Weaknesses & competitive threats     208

11.1.5      NORMON             209

11.1.5.1  Business overview 209

11.1.5.2  Products/Services/Solutions offered 209

11.1.5.3  MnM view              210

11.1.5.3.1                Right to win           210

11.1.5.3.2                Strategic choices   210

11.1.5.3.3                Weaknesses & competitive threats     211

11.1.6      DFL INDÚSTRIA E COMÉRCIO S/A            212

11.1.6.1  Business overview 212

11.1.6.2  Products/Services/Solutions offered 212

11.1.7      ULTRADENT PRODUCTS INC.    213

11.1.7.1  Business overview 213

11.1.7.2  Products/Services/Solutions offered 213

11.1.7.3  Recent developments           214

11.1.7.3.1                Deals      214

11.1.7.3.2                Expansions             214

11.1.7.3.3                Other developments             214

11.1.8      PRIMEX PHARMACEUTICALS      215

11.1.8.1  Business overview 215

11.1.8.2  Products/Services/Solutions offered 215

11.1.9      KEYSTONE INDUSTRIES                216

11.1.9.1  Business overview 216

11.1.9.2  Products/Services/Solutions offered 216

11.1.10   CLARBEN LABORATORIES           217

11.1.10.1                 Business overview 217

11.1.10.2                 Products/Services/Solutions offered 218

11.1.11   HIKMA PHARMACEUTICALS PLC               219

11.1.11.1                 Business overview 219

11.1.11.2                 Products/Services/Solutions offered 220

11.1.12   ZEYCO  221

11.1.12.1                 Business overview 221

11.1.12.2                 Products/Services/Solutions offered 222

11.1.13   NEW STETIC S.A.              223

11.1.13.1                 Business overview 223

11.1.13.2                 Products/Services/Solutions offered 224

11.1.14   CETYLITE, INC. 225

11.1.14.1                 Business overview 225

11.1.14.2                 Products/Services/Solutions offered 225

11.1.15   ICPA HEALTH PRODUCTS LIMITED        226

11.1.15.1                 Business overview 226

11.1.15.2                 Products/Services/Solutions offered 226

11.2         OTHER PLAYERS              227

11.2.1      CENTRIX, INC.   227

11.2.2      ZYMETH PHARMACEUTICAL      228

11.2.3      DMG AMERICA LLC         229

11.2.4      GC SHOWAYAKUHIN CORPORATION     230

11.2.5      YOUNG INNOVATIONS, INC.       231

11.2.6      CROSSTEX INTERNATIONAL, INC.            232

11.2.7      MARK3 (CARGUS INTERNATIONAL, INC.)             233

11.2.8      J. MORITA CORP.              234

11.2.9      KULZER GMBH 235

11.2.10   INTEGRA LIFESCIENCES CORPORATION               236

12            APPENDIX           237

12.1         DISCUSSION GUIDE        237

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                241

12.3         CUSTOMIZATION OPTIONS        243

12.4         RELATED REPORTS         243

12.5         AUTHOR DETAILS           244

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES                 26

TABLE 2                DENTAL ANESTHETICS MARKET: RISK ASSESSMENT ANALYSIS 42

TABLE 3                PROJECTED INCREASE IN NUMBER OF PEOPLE AGED OVER 65 YEARS,

BY REGION, 2019 VS. 2050 (MILLION)       53

TABLE 4                US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY SERVICES,

2021 VS. 2022       55

TABLE 5                US: RECENT DEALS BACKED BY PRIVATE EQUITY, 2020–2024           56

TABLE 6                AVERAGE PROCEDURAL COST IN TOP TEN DENTAL TOURISM DESTINATIONS (USD)            59

TABLE 7                DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60

TABLE 8                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 62

TABLE 9                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           63

TABLE 10              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 63

TABLE 11              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 64

TABLE 12              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  65

TABLE 13              DENTAL ANESTHETICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026      69

TABLE 14              AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION, 2023–2025 (USD)                 70

TABLE 15              INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER, 2024       70

TABLE 16              IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390),

BY COUNTRY, 2020–2024 (USD THOUSAND)         72

TABLE 17              EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390),

BY COUNTRY, 2020–2024 (USD THOUSAND)         72

TABLE 18              LIST OF PATENTS IN DENTAL ANESTHETICS MARKET (2022−2024)     75

TABLE 19              DENTAL ANESTHETICS MARKET: ROLE IN ECOSYSTEM       78

TABLE 20              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS               83

TABLE 21              KEY BUYING CRITERIA FOR END USERS                 83

TABLE 22              DENTAL ANESTHETICS MARKET: UNMET NEEDS  84

TABLE 23              DENTAL ANESTHETICS MARKET: END-USER EXPECTATIONS                85

TABLE 24              US-ADJUSTED RECIPROCAL TARIFF RATES                 87

TABLE 25              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR DENTAL PRODUCTS             88

TABLE 26              DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)                90

TABLE 27              DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            91

TABLE 28              DENTAL ANESTHETICS MARKET FOR LIDOCAINE, BY COUNTRY,

2023–2030 (USD MILLION)            93

TABLE 29              DENTAL ANESTHETICS MARKET FOR MEPIVACAINE, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 30              DENTAL ANESTHETICS MARKET FOR ARTICAINE, BY COUNTRY,

2023–2030 (USD MILLION)            97

TABLE 31              DENTAL ANESTHETICS MARKET FOR BUPIVACAINE, BY COUNTRY,

2023–2030 (USD MILLION)            99

TABLE 32              DENTAL ANESTHETICS MARKET FOR PRILOCAINE, BY COUNTRY,

2023–2030 (USD MILLION)            100

TABLE 33              DENTAL ANESTHETICS MARKET FOR OTHER DRUG TYPES, BY COUNTRY,

2023–2030 (USD MILLION)            102

TABLE 34              DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            104

TABLE 35              DENTAL ANESTHETICS MARKET FOR ROUTE OF ADMINISTRATION,

BY COUNTRY, 2023–2030 (USD MILLION)               105

TABLE 36             TOPICAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            107

TABLE 37              INJECTABLE ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     109

TABLE 38              INJECTABLE ANESTHETICS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)                110

TABLE 39              SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111

TABLE 40              NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113

TABLE 41              DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)            115

TABLE 42              DENTAL ANESTHETICS MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 43              DENTAL ANESTHETICS MARKET FOR DENTAL CLINICS, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 44              DENTAL ANESTHETICS MARKET FOR OTHER END USERS, BY COUNTRY

2023–2030 (USD MILLION)            120

TABLE 45              DENTAL ANESTHETICS MARKET, BY REGION, 2023–2030 (USD MILLION)            123

TABLE 46              EUROPE: DENTAL ANESTHETICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            126

TABLE 47              EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            126

TABLE 48              EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            127

TABLE 49              EUROPE: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            127

TABLE 50              GERMANY: DENTIST POPULATION, 2019–2022                 128

TABLE 51              GERMANY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET         128

TABLE 52              GERMANY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            129

TABLE 53              GERMANY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 129

TABLE 54              GERMANY: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            129

TABLE 55              ITALY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    130

TABLE 56              ITALY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            131

TABLE 57              ITALY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            131

TABLE 58              ITALY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)     131

TABLE 59              SPAIN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    132

TABLE 60              SPAIN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            133

TABLE 61              SPAIN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            133

TABLE 62              SPAIN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)     133

TABLE 63              FRANCE: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    134

TABLE 64              FRANCE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            135

TABLE 65              FRANCE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            135

TABLE 66              FRANCE: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            135

TABLE 67              UK: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET              136

TABLE 68              UK: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)                137

TABLE 69              UK: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            137

TABLE 70              UK: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)                137

TABLE 71              REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            138

TABLE 72              REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            139

TABLE 73              REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            139

TABLE 74              US: DENTAL EXPENDITURE, 2014–2023 (USD BILLION)             140

TABLE 75              NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 76              NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            142

TABLE 77              NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            142

TABLE 78              NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            142

TABLE 79              US: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)                143

TABLE 80              US: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            144

TABLE 81              US: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)                144

TABLE 82              CANADA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    145

TABLE 83              CANADA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            145

TABLE 84              CANADA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            146

TABLE 85              CANADA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            146

TABLE 86              ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            149

TABLE 87              ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            149

TABLE 88              ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 150

TABLE 89              ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            150

TABLE 90              SOUTH KOREA: FOREIGN PATIENTS VISITING DENTAL FACILITIES,

2017–2021              151

TABLE 91              SOUTH KOREA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET         151

TABLE 92              SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            152

TABLE 93              SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            152

TABLE 94              SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            152

TABLE 95              JAPAN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    153

TABLE 96              JAPAN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            154

TABLE 97              JAPAN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            154

TABLE 98              JAPAN: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            154

TABLE 99              CHINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    155

TABLE 100            CHINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            156

TABLE 101            CHINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            156

TABLE 102            CHINA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            156

TABLE 103            INDIA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    157

TABLE 104            INDIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            158

TABLE 105            INDIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            158

TABLE 106            INDIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)     158

TABLE 107            AUSTRALIA: MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    159

TABLE 108            AUSTRALIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            159

TABLE 109            AUSTRALIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 160

TABLE 110            AUSTRALIA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 111            REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            161

TABLE 112            REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            161

TABLE 113            REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            162

TABLE 114            LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 115            LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            163

TABLE 116            LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            164

TABLE 117            LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            164

TABLE 118            BRAZIL: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    165

TABLE 119            BRAZIL: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            165

TABLE 120            BRAZIL: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            165

TABLE 121            BRAZIL: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            166

TABLE 122            ARGENTINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET         166

TABLE 123            ARGENTINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            167

TABLE 124            ARGENTINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 167

TABLE 125            ARGENTINA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            167

TABLE 126            MEXICO: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET    168

TABLE 127            MEXICO: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            169

TABLE 128            MEXICO: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            169

TABLE 129            MEXICO: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            169

TABLE 130            REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            170

TABLE 131            REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)       170

TABLE 132            REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            171

TABLE 133            MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE,

2023–2030 (USD MILLION)            172

TABLE 134            MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)       172

TABLE 135            MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            173

TABLE 136            GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–

2030 (USD MILLION)       174

TABLE 137            GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            174

TABLE 138            GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY END USER,

2023–2030 (USD MILLION)            175

TABLE 139            STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL ANESTHETICS MARKET, JANUARY 2021–MARCH 2025                 177

TABLE 140            DENTAL ANESTHETICS MARKET: DEGREE OF COMPETITION 179

TABLE 141            DENTAL ANESTHETICS MARKET: REGION FOOTPRINT       183

TABLE 142            DENTAL ANESTHETICS MARKET: DRUG TYPE FOOTPRINT       184

TABLE 143            DENTAL ANESTHETICS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT 185

TABLE 144            DENTAL ANESTHETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES   188

TABLE 145            DENTAL ANESTHETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 188

TABLE 146            DENTAL ANESTHETICS MARKET: PRODUCT LAUNCHES,

JANUARY 2021–MARCH 2025         191

TABLE 147            DENTAL ANESTHETICS MARKET: DEALS, JANUARY 2021–MARCH 2025         191

TABLE 148            DENTAL ANESTHETICS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025         192

TABLE 149            DENTAL ANESTHETICS MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–MARCH 2025         192

TABLE 150            SEPTODONT HOLDING: COMPANY OVERVIEW                 193

TABLE 151            SEPTODONT HOLDING: PRODUCTS/SERVICES/SOLUTIONS OFFERED    194

TABLE 152          SEPTODONT HOLDING: PRODUCTS LAUNCHES, JANUARY 2021–MARCH 2025         195

TABLE 153            SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025       195

TABLE 154            SEPTODONT HOLDING: EXPANSIONS, JANUARY 2021–MARCH 2025             196

TABLE 155            DENTSPLY SIRONA: COMPANY OVERVIEW                 198

TABLE 156            DENTSPLY SIRONA: PRODUCTS/SERVICES/SOLUTIONS OFFERED    199

TABLE 157            DENTSPLY SIRONA: DEALS, JANUARY 2021–MARCH 2025       200

TABLE 158            PIERREL: COMPANY OVERVIEW                202

TABLE 159            PIERREL: PRODUCTS/SERVICES/SOLUTIONS OFFERED             202

TABLE 160            PIERREL: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025       203

TABLE 161            PIERREL: DEALS, JANUARY 2021–MARCH 2025                 203

TABLE 162            HUONS GLOBAL: COMPANY OVERVIEW                 205

TABLE 163            HUONS GLOBAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED    206

TABLE 164            HUONS GLOBAL: EXPANSIONS, JANUARY 2021–MARCH 2025       207

TABLE 165            HUONS GLOBAL: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025         207

TABLE 166            NORMON: COMPANY OVERVIEW             209

TABLE 167            NORMON: PRODUCTS/SERVICES/SOLUTIONS OFFERED             209

TABLE 168            DFL INDÚSTRIA E COMÉRCIO S/A: COMPANY OVERVIEW          212

TABLE 169            DFL INDÚSTRIA E COMÉRCIO S/A: PRODUCTS/SERVICES/SOLUTIONS OFFERED    212

TABLE 170            ULTRADENT PRODUCTS INC.: COMPANY OVERVIEW          213

TABLE 171            ULTRADENT PRODUCTS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    213

TABLE 172            ULTRADENT PRODUCTS INC.: DEALS, JANUARY 2021–MARCH 2025             214

TABLE 173            ULTRADENT PRODUCTS INC.: EXPANSIONS, JANUARY 2021–MARCH 2025         214

TABLE 174            ULTRADENT PRODUCTS INC.: OTHER DEVELOPMENTS,

JANUARY 2021–MARCH 2025         214

TABLE 175            PRIMEX PHARMACEUTICALS: COMPANY OVERVIEW          215

TABLE 176            PRIMEX PHARMACEUTICALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    215

TABLE 177            KEYSTONE INDUSTRIES: COMPANY OVERVIEW                 216

TABLE 178            KEYSTONE INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED    216

TABLE 179            CLARBEN LABORATORIES: COMPANY OVERVIEW          217

TABLE 180            CLARBEN LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED    218

TABLE 181            HIKMA PHARMACEUTICALS PLC: COMPANY OVERVIEW          219

TABLE 182            HIKMA PHARMACEUTICALS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    220

TABLE 183            ZEYCO: COMPANY OVERVIEW   221

TABLE 184            ZEYCO: PRODUCTS/SERVICES/SOLUTIONS OFFERED             222

TABLE 185            NEW STETIC S.A.: COMPANY OVERVIEW                 223

TABLE 186            NEW STETIC S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    224

TABLE 187            CETYLITE, INC.: COMPANY OVERVIEW 225

TABLE 188            CETYLITE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    225

TABLE 189            ICPA HEALTH PRODUCTS LIMITED: COMPANY OVERVIEW          226

TABLE 190            ICPA HEALTH PRODUCTS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED    226

TABLE 191            CENTRIX, INC.: COMPANY OVERVIEW    227

TABLE 192            ZYMETH PHARMACEUTICAL: COMPANY OVERVIEW          228

TABLE 193            DMG AMERICA LLC: COMPANY OVERVIEW                 229

TABLE 194            GC SHOWAYAKUHIN CORPORATION: COMPANY OVERVIEW   230

TABLE 195            YOUNG INNOVATIONS, INC.: COMPANY OVERVIEW          231

TABLE 196            CROSSTEX INTERNATIONAL, INC.: COMPANY OVERVIEW          232

TABLE 197            MARK3 (CARGUS INTERNATIONAL, INC.): COMPANY OVERVIEW   233

TABLE 198            J. MORITA CORP.: COMPANY OVERVIEW                 234

TABLE 199            KULZER GMBH: COMPANY OVERVIEW  235

TABLE 200            INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW   236

LIST OF FIGURES

FIGURE 1              DENTAL ANESTHETICS MARKET SEGMENTATION & REGIONAL SCOPE    24

FIGURE 2              RESEARCH DESIGN         27

FIGURE 3              PRIMARY SOURCES         30

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            32

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                33

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION                 33

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         34

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: SEPTODONT HOLDING                 35

FIGURE 9              SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL ANESTHETICS MARKET (2024) 36

FIGURE 10            BOTTOM-UP APPROACH              36

FIGURE 11            TOP-DOWN APPROACH                37

FIGURE 12            CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES ANALYSIS (2025–2030)              38

FIGURE 13            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 38

FIGURE 14            DATA TRIANGULATION METHODOLOGY                 40

FIGURE 15            DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2025 VS. 2030 (USD MILLION)         43

FIGURE 16            DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION,

2025 VS. 2030 (USD MILLION)      44

FIGURE 17            DENTAL ANESTHETICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      44

FIGURE 18            GEOGRAPHIC SNAPSHOT OF DENTAL ANESTHETICS MARKET 45

FIGURE 19            RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 46

FIGURE 20            INJECTABLE ANESTHETICS SEGMENT IN SOUTH KOREA LED ASIA PACIFIC

MARKET IN 2024                47

FIGURE 21            INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD         48

FIGURE 22            ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD       48

FIGURE 23            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    49

FIGURE 24            DENTAL ANESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          51

FIGURE 25            UK: PROJECTED NUMBER OF ADULTS (16 YEARS AND OLDER) WITH DENTAL CARIES, 2020–2050 (MILLION)                 52

FIGURE 26            DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60

FIGURE 27            TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL ANESTHETICS MARKET (JANUARY 2014–DECEMBER 2024)           74

FIGURE 28            TOP PATENT APPLICANT COUNTRIES FOR DENTAL ANESTHETICS

(JANUARY 2014–DECEMBER 2024)              75

FIGURE 29            DENTAL ANESTHETICS MARKET: VALUE CHAIN ANALYSIS            77

FIGURE 30            DENTAL ANESTHETICS MARKET: ECOSYSTEM ANALYSIS            78

FIGURE 31            DENTAL ANESTHETICS MARKET: SUPPLY CHAIN ANALYSIS              79

FIGURE 32            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN DENTAL ANESTHETICS MARKET                 82

FIGURE 33            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS               82

FIGURE 34            KEY BUYING CRITERIA FOR END USERS                 83

FIGURE 35            DENTAL ANESTHETICS MARKET: ADJACENT MARKET ANALYSIS         84

FIGURE 36            DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         122

FIGURE 37            EUROPE: DENTAL ANESTHETICS MARKET SNAPSHOT          125

FIGURE 38            NORTH AMERICA: DENTAL ANESTHETICS MARKET SNAPSHOT       141

FIGURE 39            ASIA PACIFIC: DENTAL ANESTHETICS MARKET SNAPSHOT          148

FIGURE 40            MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL ANESTHETICS

MARKET (2024) 178

FIGURE 41            DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       181

FIGURE 42            DENTAL ANESTHETICS MARKET: COMPANY FOOTPRINT       182

FIGURE 43            DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 187

FIGURE 44            EV/EBITDA OF KEY VENDORS   189

FIGURE 45            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      189

FIGURE 46            DENTAL ANESTHETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     190

FIGURE 47            DENTSPLY SIRONA: COMPANY SNAPSHOT                 199

FIGURE 48            HUONS GLOBAL: COMPANY SNAPSHOT                 206

FIGURE 49            HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT          220

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 高圧洗浄機市場 – 2030年までの世界予測 2025-06-12
• 装甲車両市場 – 2030年までの世界予測 2025-06-12
• 工業用ゴム市場 – 2030年までの世界予測 2025-06-12
• 追跡・トレースソリューション市場 – 2030年までの世界予測 2025-06-12
• エクソソーム研究市場 – 2030年までの世界予測 2025-06-10

MarketsandMarkets  出版レポート一覧